Adolor Corp (ADLR)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre

Cours de l'action
Code mnémonique : ADLR Marché : NMQ


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers
Résultats financiers
 
Value bought

90 derniers jours

 
Value sold

90 derniers jours

 
Net insiders buying

90 derniers jours

 
Trades (buy and sell)

90 derniers jours

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur Détails
2011-12-13 2011-12-12 A Achat

CUBIST PHARMACEUTICALS INC

Actionnaire important
7 908 727 +100.0%
4,25
33 612 090 USD 		7 908 727 +100.0% 4,25 33 612 090 USD
2011-12-13 2011-12-09 A Achat

CUBIST PHARMACEUTICALS INC

Actionnaire important
45 070 030 +104.1%
4,76
214 533 343 USD 		45 070 030 +104.1% 4,76 214 533 343 USD
2011-12-13 2011-12-09 A Achat

CUBIST PHARMACEUTICALS INC

Actionnaire important
1 729 130 +4.2%
4,25
7 348 803 USD 		1 729 130 +4.2% 4,25 7 348 803 USD
2011-12-09 2011-12-08 A Achat

CUBIST PHARMACEUTICALS INC

Actionnaire important
1 180 983 +2.9%
4,25
5 019 178 USD 		1 180 983 +2.9% 4,25 5 019 178 USD
2011-12-09 2011-12-07 A Achat

CUBIST PHARMACEUTICALS INC

Actionnaire important
4 306 129 +11.9%
4,25
18 301 048 USD 		4 306 129 +11.9% 4,25 18 301 048 USD
2011-12-08 2011-12-06 A Achat

MADDEN DAVID

Administrateur non-exécutif
18 425 +1.7%
4,66
85 861 USD 		18 425 +1.7% 4,66 85 861 USD
2011-12-08 2011-12-06 A Achat

MADDEN DAVID

Administrateur non-exécutif
61 650 +6.0%
4,65
286 673 USD 		61 650 +6.0% 4,65 286 673 USD
2011-12-02 2011-12-02 A Achat

NICKELSON DONALD E

Administrateur non-exécutif
35 000 +11.4%
4,62
161 700 USD 		35 000 +11.4% 4,62 161 700 USD
2011-12-02 2011-12-02 A Achat

NICKELSON DONALD E

Administrateur non-exécutif
100 000 +48.1%
4,67
467 000 USD 		100 000 +48.1% 4,67 467 000 USD
2011-12-02 2011-12-02 A Achat

NICKELSON DONALD E

Administrateur non-exécutif
72 896 +53.9%
4,73
344 798 USD 		72 896 +53.9% 4,73 344 798 USD
2011-11-30 2011-11-22 A Achat

NICKELSON DONALD E

Administrateur non-exécutif
2 643 +2.0%
4,58
12 105 USD 		2 643 +2.0% 4,58 12 105 USD
2011-11-30 2011-11-21 A Achat

NICKELSON DONALD E

Administrateur non-exécutif
24 461 +22.6%
4,59
112 276 USD 		24 461 +22.6% 4,59 112 276 USD
2011-06-27 2011-06-27 A Achat

Webster Stephen W

SVP, Finance & CFO

Dirigeant
10 000 +7.8%
1,88
18 800 USD 		10 000 +7.8% 1,88 18 800 USD
2011-06-22 2011-06-15 A Achat

Limongelli John M

SVP, General Counsel & Secr.

Dirigeant
3 010 +1.6%
1,80
5 418 USD 		3 010 +1.6% 1,80 5 418 USD
2011-06-22 2011-06-14 A Achat

Limongelli John M

SVP, General Counsel & Secr.

Dirigeant
13 190 +7.6%
1,90
25 061 USD 		13 190 +7.6% 1,90 25 061 USD
2010-12-23 2010-12-23 A Achat

DOUGHERTY MICHAEL R

President & CEO

Administrateur exécutif
30 000 +5.1%
1,18
35 400 USD 		30 000 +5.1% 1,18 35 400 USD
2010-10-29 2010-10-29 V Vente

Baker Biotech Capital (GP), LLC

Actionnaire important
376 -0.5%
1,18
445 USD 		376 -0.5% 1,18 445 USD
2010-10-29 2010-10-29 V Vente

Baker Bros. Capital (GP), LLC

Actionnaire important
14 -0.5%
1,18
17 USD 		14 -0.5% 1,18 17 USD
2010-10-29 2010-10-29 V Vente

14159 capital (GP), LLC

Actionnaire important
884 -0.5%
1,18
1 046 USD 		884 -0.5% 1,18 1 046 USD
2010-10-29 2010-10-29 V Vente

Baker / Tisch Capital (GP), LLC

Actionnaire important
60 -0.5%
1,18
71 USD 		60 -0.5% 1,18 71 USD
2010-10-29 2010-10-29 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
31 666 -0.5%
1,18
37 461 USD 		31 666 -0.5% 1,18 37 461 USD
2010-10-29 2010-10-28 V Vente

Baker Biotech Capital (GP), LLC

Actionnaire important
885 -1.1%
1,19
1 052 USD 		885 -1.1% 1,19 1 052 USD
2010-10-29 2010-10-28 V Vente

Baker Bros. Capital (GP), LLC

Actionnaire important
33 -1.1%
1,19
39 USD 		33 -1.1% 1,19 39 USD
2010-10-29 2010-10-28 V Vente

14159 capital (GP), LLC

Actionnaire important
2 086 -1.1%
1,19
2 479 USD 		2 086 -1.1% 1,19 2 479 USD
2010-10-29 2010-10-28 V Vente

Baker / Tisch Capital (GP), LLC

Actionnaire important
142 -1.1%
1,19
169 USD 		142 -1.1% 1,19 169 USD
2010-10-29 2010-10-28 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
74 670 -1.1%
1,19
88 738 USD 		74 670 -1.1% 1,19 88 738 USD
2010-10-29 2010-10-27 V Vente

Baker Biotech Capital (GP), LLC

Actionnaire important
569 -0.7%
1,30
740 USD 		569 -0.7% 1,30 740 USD
2010-10-29 2010-10-27 V Vente

Baker Bros. Capital (GP), LLC

Actionnaire important
21 -0.7%
1,30
27 USD 		21 -0.7% 1,30 27 USD
2010-10-29 2010-10-27 V Vente

14159 capital (GP), LLC

Actionnaire important
1 341 -0.7%
1,30
1 743 USD 		1 341 -0.7% 1,30 1 743 USD
2010-10-29 2010-10-27 V Vente

Baker / Tisch Capital (GP), LLC

Actionnaire important
91 -0.7%
1,30
118 USD 		91 -0.7% 1,30 118 USD
2010-10-29 2010-10-27 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
47 978 -0.7%
1,30
62 371 USD 		47 978 -0.7% 1,30 62 371 USD
2010-10-29 2010-10-27 V Vente

Baker Biotech Capital (GP), LLC

Actionnaire important
233 -0.3%
1,28
298 USD 		233 -0.3% 1,28 298 USD
2010-10-29 2010-10-27 V Vente

Baker Bros. Capital (GP), LLC

Actionnaire important
9 -0.3%
1,28
11 USD 		9 -0.3% 1,28 11 USD
2010-10-29 2010-10-27 V Vente

14159 capital (GP), LLC

Actionnaire important
550 -0.3%
1,28
702 USD 		550 -0.3% 1,28 702 USD
2010-10-29 2010-10-27 V Vente

Baker / Tisch Capital (GP), LLC

Actionnaire important
37 -0.3%
1,28
47 USD 		37 -0.3% 1,28 47 USD
2010-10-29 2010-10-27 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
19 671 -0.3%
1,28
25 120 USD 		19 671 -0.3% 1,28 25 120 USD
2010-06-02 2010-06-01 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
2 238 +0.0%
1,58
3 536 USD 		2 238 +0.0% 1,58 3 536 USD
2010-06-02 2010-06-01 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
405 401 +6.3%
1,64
664 736 USD 		405 401 +6.3% 1,64 664 736 USD
2010-06-02 2010-06-01 A Achat

14159 capital (GP), LLC

Actionnaire important
62 +0.0%
1,58
98 USD 		62 +0.0% 1,58 98 USD
2010-06-02 2010-06-01 A Achat

14159 capital (GP), LLC

Actionnaire important
11 190 +6.2%
1,64
18 348 USD 		11 190 +6.2% 1,64 18 348 USD
2010-06-02 2010-05-28 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
21 604 +0.3%
1,56
33 750 USD 		21 604 +0.3% 1,56 33 750 USD
2010-06-02 2010-05-28 A Achat

14159 capital (GP), LLC

Actionnaire important
596 +0.3%
1,56
931 USD 		596 +0.3% 1,56 931 USD
2010-06-02 2010-05-28 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
517 045 +8.8%
1,60
828 409 USD 		517 045 +8.8% 1,60 828 409 USD
2010-06-02 2010-05-28 A Achat

14159 capital (GP), LLC

Actionnaire important
14 272 +8.6%
1,60
22 867 USD 		14 272 +8.6% 1,60 22 867 USD
2010-05-27 2010-05-27 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
44 862 +0.8%
1,60
71 640 USD 		44 862 +0.8% 1,60 71 640 USD
2010-05-27 2010-05-27 A Achat

14159 capital (GP), LLC

Actionnaire important
1 238 +0.8%
1,60
1 977 USD 		1 238 +0.8% 1,60 1 977 USD
2010-05-27 2010-05-26 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
64 420 +1.1%
1,59
102 196 USD 		64 420 +1.1% 1,59 102 196 USD
2010-05-27 2010-05-26 A Achat

14159 capital (GP), LLC

Actionnaire important
1 778 +1.1%
1,59
2 821 USD 		1 778 +1.1% 1,59 2 821 USD
2010-05-27 2010-05-25 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
68 534 +1.2%
1,60
109 558 USD 		68 534 +1.2% 1,60 109 558 USD
2010-05-27 2010-05-25 A Achat

14159 capital (GP), LLC

Actionnaire important
1 892 +1.2%
1,60
3 025 USD 		1 892 +1.2% 1,60 3 025 USD
2010-05-03 2010-04-30 A Achat

14159 capital (GP), LLC

Actionnaire important
970 +0.6%
1,99
1 928 USD 		970 +0.6% 1,99 1 928 USD
2010-05-03 2010-04-30 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
35 130 +0.6%
1,99
69 824 USD 		35 130 +0.6% 1,99 69 824 USD
2010-05-03 2010-04-29 A Achat

14159 capital (GP), LLC

Actionnaire important
124 +0.1%
1,94
240 USD 		124 +0.1% 1,94 240 USD
2010-05-03 2010-04-29 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
4 508 +0.1%
1,94
8 740 USD 		4 508 +0.1% 1,94 8 740 USD
2010-04-28 2010-04-28 A Achat

14159 capital (GP), LLC

Actionnaire important
3 094 +2.0%
1,92
5 938 USD 		3 094 +2.0% 1,92 5 938 USD
2010-04-28 2010-04-28 A Achat

14159 capital (GP), LLC

Actionnaire important
962 +0.6%
1,82
1 753 USD 		962 +0.6% 1,82 1 753 USD
2010-04-28 2010-04-28 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
112 106 +2.0%
1,92
215 165 USD 		112 106 +2.0% 1,92 215 165 USD
2010-04-28 2010-04-28 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
34 838 +0.6%
1,82
63 482 USD 		34 838 +0.6% 1,82 63 482 USD
2010-04-28 2010-04-27 A Achat

14159 capital (GP), LLC

Actionnaire important
98 +0.1%
2,06
202 USD 		98 +0.1% 2,06 202 USD
2010-04-28 2010-04-27 A Achat

14159 capital (GP), LLC

Actionnaire important
217 +0.1%
2,08
451 USD 		217 +0.1% 2,08 451 USD
2010-04-28 2010-04-27 A Achat

14159 capital (GP), LLC

Actionnaire important
609 +0.4%
2,08
1 267 USD 		609 +0.4% 2,08 1 267 USD
2010-04-28 2010-04-27 A Achat

14159 capital (GP), LLC

Actionnaire important
489 +0.3%
2,08
1 016 USD 		489 +0.3% 2,08 1 016 USD
2010-04-28 2010-04-27 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
3 550 +0.1%
2,06
7 313 USD 		3 550 +0.1% 2,06 7 313 USD
2010-04-28 2010-04-27 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
7 858 +0.1%
2,08
16 342 USD 		7 858 +0.1% 2,08 16 342 USD
2010-04-28 2010-04-27 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
22 055 +0.4%
2,08
45 894 USD 		22 055 +0.4% 2,08 45 894 USD
2010-04-28 2010-04-27 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
17 709 +0.3%
2,08
36 790 USD 		17 709 +0.3% 2,08 36 790 USD
2010-04-28 2010-04-26 A Achat

14159 capital (GP), LLC

Actionnaire important
1 222 +0.8%
2,05
2 509 USD 		1 222 +0.8% 2,05 2 509 USD
2010-04-28 2010-04-26 A Achat

14159 capital (GP), LLC

Actionnaire important
11 +0.0%
2,06
23 USD 		11 +0.0% 2,06 23 USD
2010-04-28 2010-04-26 A Achat

14159 capital (GP), LLC

Actionnaire important
1 393 +0.9%
2,07
2 885 USD 		1 393 +0.9% 2,07 2 885 USD
2010-04-28 2010-04-26 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
44 258 +0.8%
2,05
90 862 USD 		44 258 +0.8% 2,05 90 862 USD
2010-04-28 2010-04-26 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
389 +0.0%
2,06
801 USD 		389 +0.0% 2,06 801 USD
2010-04-28 2010-04-26 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
50 451 +0.9%
2,07
104 489 USD 		50 451 +0.9% 2,07 104 489 USD
2010-04-28 2010-04-26 A Achat

14159 capital (GP), LLC

Actionnaire important
159 +0.1%
2,06
328 USD 		159 +0.1% 2,06 328 USD
2010-04-28 2010-04-26 A Achat

Baker Brothers Life Sciences Capital (GP), LLC

Actionnaire important
5 755 +0.1%
2,06
11 855 USD 		5 755 +0.1% 2,06 11 855 USD
2009-09-24 2009-09-22 V Vente

BVF PARTNERS L P/IL

Direct Beneficial Owner

Actionnaire important
166 000 -3.9%
1,69
280 972 USD 		166 000 -3.9% 1,69 280 972 USD
// ... existing code ... // ... rest of the file ...